Robert Morrison

Robert Morrison is a Clinical Instructor in the Department of Internal Medicine at Yale School of Medicine, Yale University. He specializes in infectious diseases with a focus on malaria and tuberculosis research. His academic affiliations include roles in clinical trials and vaccine development. Dr. Morrison holds an MD from New York Medical College (1978).

His research interests revolve around vaccine development for tropical diseases, genetic susceptibility to infections, and drug resistance mechanisms. Key projects include the PfSPZ malaria vaccine trials in Mali and investigations into CSMD1 gene associations with severe malaria outcomes. He also studies tuberculosis drug resistance and efflux pump inhibitors.

Recent publications (2023–2024) highlight clinical trial designs, genomic approaches to infectious diseases, and structural biology-driven vaccine strategies. Collaborations span international institutions in Mali and involve multidisciplinary teams addressing global health challenges.

No scientific awards are explicitly listed, but his work contributes significantly to translational medicine and global health equity initiatives. His research aligns with Yale's focus on team science and translational research programs.